Possession of a Y chromosome doesn't mean you should skip this book -- its precepts are universal in our status-obsessed society. More
7 “Triple A” Stocks to Buy
This week, seven stocks get A's ("strong buy") in Portfolio Grader's three main grading categories, Total Grade, Overall Fundamental Grade, and Quantitative Grade. More
Restaurants: Get Fit or Get Fat
Offering everything from fried fish to Fritos, these food chains are opting to pass on the health craze and instead keep pushing the caloric boundaries. More
VeriFone Can’t Win For Losing
VeriFone plunged 20% on Thursday on a pretty spectacular earnings miss. But until the company gets a new CEO to push a major turnaround, that'll only be the start. More
Francesca’s: On Sale, But Don’t Bother
Don't go looking at Francesca's as a value play after its post-earnings tumble. The boutique has several question marks and is being aggressively pulled by sentiment. More
4 Pharmaceutical Stocks to Buy Now
Four Pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More
Don’t Expect the Bond Selloff to Continue
Bond prices have ticked up over the past few weeks, with yields now above 2% on the 10-year bond, but a runaway increase is unlikely as the economy struggles More
